Mylan Deal Clears Path for Biosimilar Copy of Roche ' s Herceptin Mylan Deal Clears Path for Biosimilar Copy of Roche ' s Herceptin

Generic drugmaker Mylan said on Monday it had reached a settlement with Roche providing"a clear pathway" for the launch of its biosimilar version of the Swiss company ' s top-selling breast cancer drug Herceptin in major markets.Reuters Health Information
Source: Medscape Pathology Headlines - Category: Pathology Tags: Hematology-Oncology News Source Type: news